Eli Lilly

Eli Lilly posts promising PhIII migraine results, but settles into the pack in the last leg of the race to the FDA
Endpoints
Sun, 06/11/17 - 04:58 pm
Eli Lilly
migraines
galcanezumab
ADA preview: 5 things to watch in diabetes
BioPharma Dive
Sun, 06/11/17 - 09:30 am
ADA
diabetes
Jardiance
Eli Lilly
Boehringer Ingelheim
Lantus
Tresiba
JNJ
Novo Nordisk
PCSK9 inhibitors
Amgen Regeneron
Sanofi
Apple
Google
insulin
Lilly preps galcanezumab for 2017 filing
BioPharma Dive
Sun, 06/11/17 - 09:15 am
Eli Lilly
galcanezumab
migraines
FDA
Lilly drops $55M for access to new class of diabetes drugs
BioPharma Dive
Thu, 06/8/17 - 09:58 pm
Eli Lilly
diabetes
dual amylin calcitonin receptor agonists
DACRAs
Key Bioscience
KBP-042
Top 10 diabetes drugs by 2016 sales
Fierce Pharma
Thu, 06/8/17 - 10:04 am
diabetes
Sanofi
Novo Nordisk
Eli Lilly
Merck
Lantus
Januvia
Victoza
Levemir
Humalog
Novolog
Invokana
Lilly's Strattera faces first wave of generic competition
BioPharma Dive
Fri, 06/2/17 - 11:31 am
Eli Lilly
Strattera
generics
ADHD
Apotex
Aurobindo
Glenmark
Teva Pharmaceutical
Top Presentations to Look for at ASCO
Yahoo/24-7 Wall St
Tue, 05/30/17 - 11:35 am
ASCO 2017
Merck
AbbVie
Eli Lilly
Bluebird Bio
Epizyme
Juno Therapeutics
Kite
Merus
Eli Lilly-backed Symic raises $30M round as it preps for a pivotal trial
Endpoints
Tue, 05/23/17 - 08:23 am
Eli Lilly
Symic
clinical trials
osteoarthritis
matrix biology
Nevada bill could force Sanofi, Novo and Lilly to reveal their insulin pricing secrets
Fierce Pharma
Mon, 05/22/17 - 07:48 pm
Nevada
drug pricing
Sanofi
Novo Nordisk
insulin
Eli Lilly
diabetes
Former Lilly employee wins an ironic lawsuit over disability benefits
Stat
Mon, 05/22/17 - 12:20 pm
Eli Lilly
disabilities
fibromyalgia
Cymbalta
7 Areas to watch from the ASCO abstracts
BioPharma Dive
Fri, 05/19/17 - 11:35 am
ASCO 2017
oncology
Incyte
Merck
Eli Lilly
CAR-T
NewLink Genetics
Amgen
Roche
Kite Pharma
Juno Therapeutics
ASCO: Lilly's abemaciclib vs. Pfizer's Ibrance? Too early to make a call, analysts say
Fierce Pharma
Thu, 05/18/17 - 08:00 pm
ASCO 2017
Eli Lilly
Pfizer
abemaciclib
Ibrance
breast cancer
Playing catch-up, Eli Lilly is hustling positive PhIII CGRP migraine data to the FDA as late-stage rivalry heats up
Endpoints
Fri, 05/12/17 - 11:39 am
Eli Lilly
migraines
galcanezumab
Novo’s diabetes medication Victoza keeps growing, despite Lilly’s market-share creep
Fierce Pharma
Thu, 05/4/17 - 10:08 am
Novo Nordisk
Victoza
diabetes
Eli Lilly
Trulicity
These 7 Drugmakers Relied on Price Hikes for 100% of Their Earnings Growth in 2016
Motley Fool
Sat, 04/29/17 - 10:12 am
earnings
drug pricing
Biogen
Eli Lilly
AbbVie
Allergan
Merck
Pfizer
Amgen
2 Reasons Eli Lilly is Getting Crushed
Barron's
Wed, 04/26/17 - 12:00 am
Eli Lilly
earnings
Jardiance
diabetes
baricitinib
Deal charge pushes drugmaker Eli Lilly to 1Q loss
Yahoo/AP
Tue, 04/25/17 - 11:30 am
earnings
Eli Lilly
CoLucid Pharmaceuticals
M&A
[video]Eli Lilly CEO Says Diabetes Is ‘Core Engine’ to Strategy
Bloomberg
Tue, 04/25/17 - 11:20 am
Eli Lilly
Dave Ricks
Pharma CEOs
diabetes
Eli Lilly’s 1Q17 Estimates for Elanco
Market Realist
Mon, 04/24/17 - 10:15 am
Eli Lilly
Elanco
animal health
earnings
Eli Lilly says breast cancer combination treatment improved survival rates in late-stage trial
Marketwatch
Mon, 04/24/17 - 10:07 am
Eli Lilly
advanced breast cancer
clinical trials
abemaciclib

Pages